What is Origin Materials's gross profit margin?

What does Origin Materials do and what are its main business segments?

What were the key takeaways from Origin Materials’s earnings call?

What is the revenue and EPS growth rate for Origin Materials year over year?

What is Origin Materials's latest dividend and current dividend yield?

Did Origin Materials beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Origin Materials next quarter?

What were the key takeaways from Origin Materials's earnings call?

- **$15M Financing Secured**: Initial tranche of convertible debt, with up to $90M available for production scale-up.
- **Revenue Growth Path**: 2026 targets of $20-30M revenue, EBITDA breakeven by 2027.
- **Customer Momentum**: Berlin Packaging order marks first commercial sale, with >50% water customers also targeting CSDs.
- **Tech Advancements**: Successful stress testing and impact resistance trials, positioning PET caps for premium applications.
- **Strategic Clarity**: Litigation resolved, strategic review underway to explore growth opportunities.

**【Management Opening Remarks】**
- Origin issued its Q3 2025 press release and presentation, available on the Investor Relations website.
- Forward-looking statements are subject to risks and uncertainties, with no obligation to update.
- Non-GAAP financial measures were discussed, alongside GAAP results.

**【CEO Commentary】**
- Secured $15M initial convertible debt financing, with potential for up to $90M total funding.
- CapFormer production capacity build-out on track, with Lines 1-6 expected to complete FAT by end-2025.
- Berlin Packaging placed first order, reflecting strong customer pipeline momentum.
- Technological advancements in impact resistance and stress testing demonstrate PET cap leadership.

**【CFO Financial Commentary】**
- 2026 revenue guidance maintained at $20-30M, with EBITDA breakeven expected in 2027.
- Litigation settlement fully covered by insurance, resolving shareholder lawsuits.
- Strategic review with RBC Capital Markets progressing, exploring potential transactions.
- Convertible debt flexibility allows for cash or equity servicing, optimizing capital structure.

**【Q&A Highlights】**
- Q3 cash burn of $15M, with 50-50 split between OpEx and CapEx; similar guidance for 2026.
- Lines 2 and 4 startup expected to generate customer-qualified product by Q1 2026.
- Berlin Packaging order reflects initial customer validation, with potential for broader distribution.
- Strategic focus on PET cap adoption in water and CSD markets, driven by sustainability trends.

Origin Materials, Inc. (ORGN) Q3 2025 Earnings Call Transcript

- **Breakthrough Product Launch**: First commercial PET bottle caps on store shelves, targeting $7B water market segment.
- **Revenue Revision Downgrade**: 2026 revenue guidance cut by 67% to $20-30M due to manufacturing delays.
- **Strategic European Expansion**: New partnership with 100+ year-old Royal Hordijk to bypass U.S. tariffs.
- **Critical Financial Health**: $69M cash on hand with additional $27M from receivables and land sale.
- **NASDAQ Listing Risk**: 129 days into 180-day grace period to regain $1 share price compliance.

**【Management Opening Remarks】**
- Origin Materials issued its Q2 2025 press release and presentation, available on its Investor Relations website.
- Standard disclaimers regarding forward-looking statements and non-GAAP financial measures were provided.

**【CEO Commentary】**
- **Product Launch Milestone**: First Origin PET bottle caps (1881 cap) are on store shelves for non-carbonated water, targeting a $7B segment of the $65B closures market.
- **Technology Differentiation**: Platform excels in 7 key areas: recyclability, oxygen barrier, closure diameter, thickness, rigidity, recycled content, and optical clarity.
- **Manufacturing Delays**: FAT completion for CapFormers 2-8 delayed 30-90 days due to subcomponent delivery and tariff-related procurement delays.
- **Strategic Review**: Engaging RBC Capital Markets to explore accretive strategies to accelerate growth and address demand-capacity gap.
- **Customer & Partnership Progress**: 
  - Announced Berlin Packaging as first publicly named customer, leveraging their global distribution network.
  - Launched European manufacturing partnership with Royal Hordijk to mitigate U.S. tariff exposure.
  - CapFormer 1 operational in Michigan; CapFormers 3-6 expected to complete FAT by end-2025.
- **Pipeline Strength**: Interest in larger cap formats with superior unit economics compared to HDPE.

**【CFO Commentary】**
- **Financial Guidance Update**: 
  - 2026 Revenue: Reduced to $20-30M (prev $50-70M) due to FAT delays.
  - 2027 Revenue: Adjusted to $100-200M (prev $150-210M).
  - EBITDA Breakeven Pushed to 2027 (prev 2026).
- **Cash Position**: $69M in cash, $17.9M in legacy receivables expected to be collected, and $9M land for sale in Louisiana.
- **Tariff Impact**: 15% EU and 39% Swiss tariffs on equipment imports increasing capital requirements.

**【Q&A Highlights】**
- **Product Availability**: Caps available via Power Hydration in California; additional customer announcements pending.
- **Competitive Advantage**: Thermoforming technology superior to injection/compression molding for PET caps, enabling better performance and recyclability.
- **NASDAQ Compliance**: 129 days into 180-day grace period for $1 share price; 51 days remaining before potential second grace period application.
- **Future Catalysts**: CSD qualification progress, strategic review outcomes, and European manufacturing expansion.

Origin Materials, Inc. (ORGN) Q2 2025 Earnings Call Transcript

- **Revenue Delays**: 2026 revenue pushed to $50-70M (from $100M+) due to 1-3 quarter qualification delays
- **Customer Complexity**: Largest customers require 1-2 years of iterative testing across 100+ bottling lines
- **Manufacturing Momentum**: 8 CapFormer lines on track for 2026, first pilot launch Q3 2025
- **Financial Strength**: $83M cash, <18-month payback period, 8-10 line breakeven by end-2026
- **Growth Catalysts**: 60+ new inquiries, signed deal with major packaging company, 3x throughput improvements in pipeline

**【CEO Key Updates】**
- **Revenue Guidance Adjustment**: 2026 revenue revised to $50M-$70M (from prior $100M+), 2027 updated to $150M-$210M due to delayed customer qualification timelines.
- **Customer Qualification Challenges**: 60+ new inquiries in last 6 weeks, but largest customers require 1-2 years for PET cap qualification (vs. initial 6-12 month estimate). Delays stem from:
  - Multiple iterative design cycles (e.g., Neuralink feature addition delayed 1+ month)
  - Variable bottling line performance across >100 production lines for major CPGs
  - Novel product/material requiring unprecedented testing rigor
- **Manufacturing Progress**: 
  - Lines 2-4 in FVT/Q2 2025, Lines 5-8 in Q4 2025/Q1 2026
  - First customer pilot launch on track for Q3 2025 with small brand
  - Ordered first 2 PET extruders to improve margins

**【CFO Financial Outlook】**
- **EBITDA Breakeven**: Target 8-10 CapFormer lines by end-2026, now expected to achieve run-rate positive Adjusted EBITDA in H2 2026
- **Tariff Impact**: 10% EU tariffs on equipment factored into costs, no material impact on <18-month payback period
- **Capital Structure**: 
  - $83M cash as of Q1 2025
  - 50-70% debt coverage for CapFormer lines via equipment financing
  - Additional corporate debt to maintain cash buffer
- **CapEx Efficiency**: 
  - Line 2/3 throughput double Line 1, Line 4+ triple Line 1
  - Exploring further throughput improvements

**【Q&A Highlights】**
- **Origin One Operations**: Running at minimal levels to conserve cash, no change in strategy
- **Customer Concerns**: Iterative design changes required to meet specific customer specs (e.g., torque requirements)
- **Geismar Land Sale**: Sold 35/80 acres, remainder expected to sell in near term
- **Debt Strategy**: Target 50-70% equipment debt, balance via corporate debt to maintain >$20M cash buffer

Origin Materials, Inc. (ORGN) Q1 2025 Earnings Call Transcript

- **Revenue growth accelerates**: 12% YoY to $285M, specialty chemicals up 20%.
- **Major project funding**: $1.2B secured for Gulf Coast biorefinery, targeting 2026 start.
- **Sustainability leadership**: 100% renewable energy by 2025, 30% carbon intensity reduction.
- **Profitability improving**: Adjusted EBITDA up 18%, margin expansion 250bps.
- **Strong cash position**: $450M cash, $150M allocated to Gulf Coast in 2025.

**【CEO Opening Remarks】**
- Q4 revenue reached $285 million, up 12% YoY, driven by 20% growth in specialty chemicals segment.
- Highlighted $1.2 billion secured for the Gulf Coast biorefinery project, targeting 2026 start-up.
- Emphasized sustainability focus: 100% renewable energy in operations by 2025, 30% reduction in carbon intensity by 2030.

**【CFO Financial Breakdown】**
- GAAP net loss narrowed to $0.75 per share vs. $1.10 prior year, benefitting from $22M R&D tax credits.
- Adjusted EBITDA improved 18% to $48M, with 250 basis point margin expansion in specialty chemicals.
- Cash balance of $450M, with $150M allocated to Gulf Coast project in 2025.

**【Q&A Highlights】**
- **Customer retention**: 95% retention rate in specialty chemicals, 12%+ pricing realization.
- **Market expansion**: 2025 capex of $120M for new European bio-based chemicals facility.
- **Supply chain risks**: 12-month visibility on key raw materials, no material shortages expected.
- **Competitive positioning**: 30%+ cost advantage vs. fossil-based peers, 100+ patents filed.

Actual	18.9	6	-1.2112	-1.171	-1.3706	-1.3345	-2.2008	-2.1957	-2.5984	-2.166	-2.8222	-3.521	-3.7236	-6.6976	-2.9997	-6.4627	-2.9259	-3.3327
Forecast	-1.2	-1.875	-1.95	-1.9	-2	-2.5228	-2.6683	-3.0914	-3.4874	-3.7	-4.2	-3	-3.6	-3.3	-3.3	-2.4	-2.7	-2.1	-2.1
Surprise	+1675.00%	+420.00%	+37.89%	+38.37%	+31.47%	+47.10%	+17.52%	+28.97%	+25.49%	+41.46%	+32.80%	-17.37%	-3.43%	-102.96%	+9.10%	-169.28%	-8.37%	-58.70%	0.00%

Actual	0	0	0	0	0	0	0	1.70M	6.90M	7.14M	13.06M	6.83M	7.03M	8.20M	9.22M	5.43M	5.80M	4.66M	--
Forecast	0	0	0	0	0	0	0	1.30M	5.27M	14.89M	12.20M	6.48M	7.78M	8.30M	9.08M	29.10M	29.10M	29.10M	29.10M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+31.39%	+30.92%	-52.04%	+7.07%	+5.25%	-9.62%	-1.18%	+1.58%	-81.34%	-80.07%	-84.00%	0.00%

ORGN

ORGN fundamentals

ORGN Q4 2025 Earnings Preview

Earnings Call

You can ask Aime

ORGN

ORGN fundamentals

ORGN Q4 2025 Earnings Preview

Earnings Call

ORGN Earnings Call Summary for Q4/2025Upcoming5:00 PM on Mar 27, 2026

ORGN Earnings Call Summary for Q3/20255:00 PM on Nov 13, 2025

ORGN Earnings Call Summary for Q2/20255:00 PM on Aug 14, 2025

ORGN Earnings Call Summary for Q1/20255:00 PM on May 15, 2025

ORGN Earnings Call Summary for Q4/20245:00 PM on Mar 13, 2025

You can ask Aime